|Articles|July 1, 2018
- BioPharm International-07-01-2018
- Volume 31
- Issue 7
BioPharm International, July 2018 Issue (PDF)
Click the title above to open the BioPharm International July 2018 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 7 years ago
Seeking Regulatory Adviceover 7 years ago
Be Quick, But Don’t Hurryover 7 years ago
Biopharma Seeks Balanceover 7 years ago
Industry 4.0 in Biopharmaceutical Manufacturingover 7 years ago
Biosimilars Raise Manufacturing and Regulatory Challengesover 7 years ago
Advances in Analytics for Bioprocessingover 7 years ago
A Look into the Future of Biopharmaceutical Qualityover 7 years ago
Regulating Biologicsover 7 years ago
The Challenge of Disruptive Technologies in BioprocessingNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
How CDMO Alliances Can Provide End-to-End Service that Reduces Drug Development Time and Costs
2
First-in-Human Study Validates Safety of Next-Generation mRNA–LNP Platform
3
Industry Outlook 2026: Key Forces Transforming Drug Pipelines (Part 2)
4
FDA Clears PharmaResearch IND for Nano-Based Cancer Drug PRD-101
5
